| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/27/2008 | US20080076673 Engineered binding proteins |
| 03/27/2008 | US20080076179 Sugar and lipid metabolism regulators in plants |
| 03/27/2008 | US20080076178 Methods for the production of plants resistant to HPPD herbicides |
| 03/27/2008 | US20080076177 Plasmid comprising nucleotide sequences coding vaccine specific to newcastle disease virus hemagglutinin-neuraminidase (HN) for use in prevention and treatment of viral diseases in plants |
| 03/27/2008 | US20080076176 De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
| 03/27/2008 | US20080076175 Generating transgenic lymphoid cell comprising sequences coding immunoglobulin epitope for use in tissue targeted therapies |
| 03/27/2008 | US20080076174 Using site specific mutation as tool in directed protein evolution |
| 03/27/2008 | US20080076173 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 03/27/2008 | US20080076172 Vectors for tissue-specific replication |
| 03/27/2008 | US20080076151 Compositions for controlling hair growth |
| 03/27/2008 | US20080076148 Using presence hyaluronic acid on surface of cell as evaluative tool in screening for preferential progenitor cells |
| 03/27/2008 | US20080076146 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents |
| 03/27/2008 | US20080076145 Transgenic flies expressing tau and amyloid precursor fragment |
| 03/27/2008 | US20080076141 Nucleotide sequences coding transferase for use in identifying modulators for prevention and treatment of cell proliferative diseases |
| 03/27/2008 | US20080076136 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement |
| 03/27/2008 | US20080076126 Using blot analysis to monitor induction of monooxygenases in plants; enhancing biosynthesis of phenylpropanoids, alkaloids, terpenoids, lipids, cyanogenic glycosides, and glucosinolates |
| 03/27/2008 | US20080076114 Method for preparing agglutinatable platelet fragments and the use thereof |
| 03/27/2008 | US20080075751 Method for IN VIVO, EX VIVO and IN VITRO rapair and regeneration of cartilage and collagen and bone remodeling |
| 03/27/2008 | US20080075740 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 03/27/2008 | US20080075737 inducing an immune response to an HIV antigen; genetic engineered polypeptide; inserted into cell; improves or restores the blood clotting time, blood disorders; gene therapy |
| 03/27/2008 | US20080075736 Materials and methods for respiratory disease control in canines |
| 03/27/2008 | US20080075735 Demethylated and/or oxidized membrane DNA |
| 03/27/2008 | US20080075733 receptor for advanced glycosylation end products polypeptide directly linked to a polypeptide comprising a CH2 domain of an immunoglobulin; biodrug for treating amyloidosis, Alzheimer's disease, cancer, autoimmune disease, inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis |
| 03/27/2008 | US20080075732 Preparation of Antigen-Presenting Human Gamma-Delta T Cells and Use in Immunotherapy |
| 03/27/2008 | US20080075727 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/27/2008 | US20080075726 Anti-IL-6 monoclonal antibodies and uses thereof |
| 03/27/2008 | US20080075723 Endotheliase 2 ligands |
| 03/27/2008 | US20080075720 fusion proteins comprising antibody variable domains that binds to factor B and a targeting moiety comprising a complement receptor or fragment, used to reduce or prevent airway hyperresponsiveness and inflammation, for treating ischemia-reperfusion injuries, rhinitis and respiratory system disorders |
| 03/27/2008 | US20080075717 Antigen Imitating Extracellular Areas of Membrane Proteins of Type III Produced from Intracellular Pathogenic Micro-Organisms, Derived Conformational Antibodies and the Use Thereof |
| 03/27/2008 | US20080075715 modified polypeptides, whereby the modification results in a reduced number of potential lymphocyte epitopes that provides a reduced propensity for the polypeptide to elicit an immune response upon administration to a human, but retain the ability to bind to CD52 antigens |
| 03/27/2008 | US20080075713 isomerase enzymes and ATP-binding cassette (ABC) transport proteins, used for controlling metabolism of triglycerides; diagnosis, prevention and treatment of metabolic disorders |
| 03/27/2008 | US20080075705 induction of endogenous heat shock proteins in tumor cells, bysimple heat treatment as a method for augmenting antitumor vaccine potency |
| 03/27/2008 | US20080075704 Time varying electromagnetic force ("TVEMF") expanded blood stem cells from a mammal, used for repair of tissues |
| 03/27/2008 | US20080075703 using a mixture of cells including connective tissue cells transfected or transduced with genes encoding transforming growth factors or bone morphogenic proteins, used for regenerating cartilage and treatment of osteoarthritis; somatic cell gene therapy; tissue-targeted therapy |
| 03/27/2008 | US20080075702 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 03/27/2008 | US20080075700 Method and composition for treating diabetes |
| 03/27/2008 | US20080075699 contact with an antibody or fragments produced from hybridoma cell lines and analyzing binding; used for gene therapy and for treating deteriorated bone or cartilage tissue |
| 03/27/2008 | US20080075698 Brain-Localizing Bone Marrow Progenitor cells |
| 03/27/2008 | DE102007003670A1 Doubly transgenic nonhuman mammal useful as a lung cancer model has a genome including protooncogene and oncogene sequences |
| 03/27/2008 | DE102006060247A1 Differentiating stem cells or precursor cells for tissue type, especially for use in therapy, involves treating the cells with extracts containing active ingredients for such differentiation and then culturing and differentiating |
| 03/27/2008 | CA2700360A1 In vivo transformation of pancreatic acinar cells into insulin-producing cells |
| 03/27/2008 | CA2664093A1 Cell delivery matrices |
| 03/27/2008 | CA2663978A1 Stem cell culture medium and method |
| 03/27/2008 | CA2663072A1 Expansion method for adult stem cells from blood, particularly peripheral blood, and relative application in medical field |
| 03/27/2008 | CA2656175A1 Pluripotent stem cell culture |
| 03/27/2008 | CA2649387A1 Novel gene disruptions, compositions and methods relating thereto |
| 03/26/2008 | EP1903113A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 03/26/2008 | EP1903112A2 Activin receptors-like kinase(alk), belonging to the TGF receptor family and/or to the BMP receptor family |
| 03/26/2008 | EP1903111A2 Extended cDNAs for secreted proteins |
| 03/26/2008 | EP1903107A1 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 03/26/2008 | EP1903106A1 Method for manufacturing agglutinable thrombocyte fragments and their application |
| 03/26/2008 | EP1903058A2 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 03/26/2008 | EP1903057A2 Lipoprotein-regulating medicaments |
| 03/26/2008 | EP1902129A1 Novel enzymes for use in enzymatic bleaching of food products |
| 03/26/2008 | EP1902128A2 Apparatus and methods for preparing tissue grafts |
| 03/26/2008 | EP1902127A2 Bioreactor system and method of enhancing functionality of muscle cultured in vitro |
| 03/26/2008 | EP1901765A1 Intralesional treatment of psoriasis |
| 03/26/2008 | EP1901680A2 Methods and compositions for enhancing vascular access |
| 03/26/2008 | EP1866429A4 Methods of islet isolation and transplantation |
| 03/26/2008 | EP1743024A4 A new method of expanding cord blood cells |
| 03/26/2008 | EP1458880B1 Isolation tool for viable c-kit expressing cells |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | EP1090128B1 Modified vitamin-k-dependent polypeptides |
| 03/26/2008 | EP1033953B1 Method of cross-linking keratin-based films, sheets, and bulk materials |
| 03/26/2008 | EP0871482B1 Recombinant vesiculoviruses and their uses |
| 03/26/2008 | CN101151362A In vitro techniques for use with stem cells |
| 03/26/2008 | CN101151276A Method of producing protein by using hamster IGF-1 |
| 03/26/2008 | CN101151035A Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease |
| 03/26/2008 | CN101150954A Methods and compositions for encapsulation of cells |
| 03/26/2008 | CN101149377A Antibody for detecting aspergillus |
| 03/26/2008 | CN101148671A Spartina anglica sodium hydrogen pump protein gene SaNHX and application thereof |
| 03/26/2008 | CN101148661A Human papilloma virus 16 type coat protein virus-like particles, preparation method and use thereof |
| 03/26/2008 | CN101148657A Construction for tissue engineering cartilage modified by transforming growth factor beta2 gene |
| 03/26/2008 | CN101148656A Construction method for tissue engineering liver unit and tissue engineering liver unit |
| 03/26/2008 | CN101148655A Method for growing cell clone ball on cover glass |
| 03/26/2008 | CN101148654A Method for separating and purifying bi(5-formylfurfuryl)ether |
| 03/26/2008 | CN101148653A Method for inhibiting brown stain generation of cymbidium plant tissue culture |
| 03/26/2008 | CN101148474A Human resource vessel endothelium growth factor monoclonal antibody and preparation method thereof |
| 03/26/2008 | CN101147807A Substances for preventing and treating autoimmune diseases |
| 03/26/2008 | CN101147469A Method for inducing litsea cubeta multiple shoot |
| 03/26/2008 | CN101147467A Method for improving induction rate of turf grass embryonic callus |
| 03/26/2008 | CN101147466A Minitype ginger seedling tissue culture fast propagating culture medium and tissue culture fast propagating method |
| 03/26/2008 | CN101147463A Polysiphonia urceolata sporophyte direct seedling formation method |
| 03/26/2008 | CN100376671C Hybridized tumour cell strain of anti hpatitis B virus surface antigen and its monoclonal antibody |
| 03/26/2008 | CN100376670C System for culturing human embryonic stem cell and culturing method |
| 03/26/2008 | CN100376669C Treatment method for biological erythrocyte volume long time stabilization |
| 03/26/2008 | CN100376290C Antigenic peptides derived from telomerase |
| 03/25/2008 | US7348474 Inbred corn line G06-NP2907 |
| 03/25/2008 | US7348469 Plant farnesyltransferases |
| 03/25/2008 | US7348419 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
| 03/25/2008 | US7348418 Comprises nucleotide sequences coding oncogenic polypeptides for diagnosis, detection and treatment of cancer |
| 03/25/2008 | US7348414 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
| 03/25/2008 | US7348413 Monoclonal antibodies for use in diagnosis, prevention and treatment of cell proliferfative disorders; immunotherapy; immunodiagnostics |
| 03/25/2008 | US7348412 Ouabain-specific monoclonal antibodies |
| 03/25/2008 | US7348410 Flea head, nerve cord, hindgut and malpighian tubule proteins |
| 03/25/2008 | US7348408 Membrane protein fusion for use as diagnostic tool in genetic engineering; reporter gene expression |
| 03/25/2008 | US7348407 Stress-responsive activator of p300 (strap) protein |
| 03/25/2008 | US7348406 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/25/2008 | US7348179 IRES enabled gene trapping in plants |
| 03/25/2008 | US7348177 Expression of HIV polypeptides and production of virus-like particles |